Evidence map›Paper›PMID 26966364›Full record

ArticleNeuropsychiatric disease and treatment2016

Attitudes toward metabolic adverse events among patients with schizophrenia in Japan.

Norio Sugawara, Norio Yasui-Furukori, Manabu Yamazaki, Kazutaka Shimoda, Takao Mori, Takuro Sugai, Hiroshi Matsuda, Yutaro Suzuki, Yoshitake Minami, Yuji Ozeki and 3 more

Abstract read
In one paragraph

Article in Neuropsychiatric disease and treatment, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Physical Health Literacy and Health-related Behaviors in Patients with Psychosis.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2019
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Norio SugawaraAomori Prefectural Center for Mental Health and Welfare, Aomori, Japan; Department of Neuropsychiatry, Hirosaki University School of Medicine, Hirosaki, Japan; Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan.
Norio Yasui-FurukoriDepartment of Neuropsychiatry, Hirosaki University School of Medicine, Hirosaki, Japan; Japanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan.
Manabu YamazakiJapan Psychiatric Hospital Association, Tokyo, Japan.
Kazutaka ShimodaJapanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan; Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, Japan.
Takao MoriJapan Psychiatric Hospital Association, Tokyo, Japan.
Takuro SugaiJapanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan; Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Hiroshi MatsudaJapan Psychiatric Hospital Association, Tokyo, Japan.
Yutaro SuzukiJapanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan; Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Yoshitake MinamiJapan Psychiatric Hospital Association, Tokyo, Japan.
Yuji OzekiJapanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan; Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, Japan.
Kurefu OkamotoJapan Psychiatric Hospital Association, Tokyo, Japan.
Toyoaki SagaeDepartment of Health and Nutrition, Yamagata Prefectural Yonezawa University of Nutrition Sciences, Yonezawa, Japan.
Toshiyuki SomeyaJapanese Society of Clinical Neuropsychopharmacology, Tokyo, Japan; Department of Psychiatry, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMetabolic syndrome is a growing concern among patients with schizophrenia because metabolic abnormalities are widely regarded as a major risk factor for cardiovascular disease and premature death. The current study assessed attitudes toward metabolic adverse events among patients with schizophrenia.

methodsA brief questionnaire was constructed to investigate patient recognition of the following broad areas: dietary habits, lifestyle, self-monitoring, knowledge, and medical practice. Between January 2012 and June 2013, questionnaires were sent to patients associated with 520 outpatient facilities and 247 inpatient facilities belonging to the Japan Psychiatric Hospital Association. All of the participants (n=22,072; inpatients =15,170, outpatients =6,902) were diagnosed with schizophrenia based on the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, or the International Classification of Diseases, tenth revision.

resultsApproximately 55.0% (8,069/14,669) of inpatients and 44.8% of outpatients (2,978/6,649) reported that they did not exercise at all. Although 60.9% (4,116/6,760) of outpatients reported that they felt obese, only 35.6% (5,261/14,794) of inpatients felt obese. More than half of the inpatients (51.2%; 7,514/14,690) and outpatients (60.8%; 4,086/6,721) hoped to receive regular blood tests to prevent weight gain and diseases such as diabetes.

conclusionAlthough more than half of patients hoped to prevent weight gain and diabetes, only a minority of patients were mindful of eating balanced meals and having physical exercise. Educational efforts and the promotion of the best pharmacotherapy and monitoring practices are needed for patients with schizophrenia.

Indexed as

attitudeJapanmetabolic syndromeschizophrenia

Identifiers

PMID26966364
PMCPMC4771408

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.